Related references
Note: Only part of the references are listed.Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy
Christine Barrett et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2020)
Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
Hannah A. Blair
DRUGS (2019)
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA
Pantelis Sarafidis et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2019)
Review of the efficacy of AST-120 (KREMEZIN®) on renal function in chronic kidney disease patients
Mayumi Asai et al.
RENAL FAILURE (2019)
Mutation-specific Fabry disease patient-derived cell model to evaluate the amenability to chaperone therapy
Malte Lenders et al.
JOURNAL OF MEDICAL GENETICS (2019)
Wnt/β-catenin links oxidative stress to podocyte injury and proteinuria
Lili Zhou et al.
KIDNEY INTERNATIONAL (2019)
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
Hiddo J. L. Heerspink et al.
LANCET (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Inotersen: new promise for the treatment of hereditary transthyretin amyloidosis
Veena Mathew et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2019)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Hertzel C. Gerstein et al.
LANCET (2019)
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
F. C. Fervenza et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Growth and antibiotic resistance acquisition of Escherichia coli in a river that receives treated sewage effluent
Yoshihiro Suzuki et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2019)
Ravulizumab (ALXN1210) vs eculizumab in C5-inhibitor-experienced adult patients with PNH: the 302 study
Austin G. Kulasekararaj et al.
BLOOD (2019)
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study
Jong Wook Lee et al.
BLOOD (2019)
Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019
William T. Cefalu et al.
DIABETES CARE (2019)
The Spanish Society of Nephrology (SENEFRO) commentary to the Spain GBD 2016 report: Keeping chronic kidney disease out of sight of health authorities will only magnify the problem
Alberto Ortiz et al.
NEFROLOGIA (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Treating Disease at the RNA Level with Oligonucleotides
Arthur A. Levin
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Targeting senescent cells alleviates obesity-induced metabolic dysfunction
Allyson K. Palmer et al.
AGING CELL (2019)
Epithelial innate immunity mediates tubular cell senescence after kidney injury
Heng Jin et al.
JCI INSIGHT (2019)
Probiotics, prebiotics and amelioration of diseases
Yu-Ling Tsai et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan?
Beatriz Fernandez-Fernandez et al.
CLINICAL KIDNEY JOURNAL (2019)
The renaissance of complement therapeutics
Daniel Ricklin et al.
NATURE REVIEWS NEPHROLOGY (2018)
Cellular senescence in the aging and diseased kidney
F. A. Valentijn et al.
JOURNAL OF CELL COMMUNICATION AND SIGNALING (2018)
Membranous Nephropathy: Approaches to Treatment
Andrew S. Bomback et al.
AMERICAN JOURNAL OF NEPHROLOGY (2018)
A nephron model for study of drug-induced acute kidney injury and assessment of drug-induced nephrotoxicity
Yueyang Qu et al.
BIOMATERIALS (2018)
Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease
Juan F. Navarro-Gonzalez et al.
DIABETES CARE (2018)
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
Gina A. Montealegre Sanchez et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Bardoxolone-the Phoenix?
Robert D. Toto
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Drug repurposing in kidney disease
Usha Panchapakesan et al.
KIDNEY INTERNATIONAL (2018)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Daniel J. Wallace et al.
LANCET (2018)
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortiz et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Blocking Macrophage Migration Inhibitory Factor Protects Against Cisplatin-Induced Acute Kidney Injury in Mice
Jinhong Li et al.
MOLECULAR THERAPY (2018)
Enzyme replacement therapy dose and Fabry nephropathy
Alberto Ortiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
Katherine R. Tuttle et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Albumin downregulates Klotho in tubular cells
Beatriz Fernandez-Fernandez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
D. Adams et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
TWEAK increases CD74 expression and sensitizes to DDT proinflammatory actions in tubular cells
Lara Valino-Rivas et al.
PLOS ONE (2018)
TWEAK and RIPK1 mediate a second wave of cell death during AKI
Diego Martin-Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Phenytoin inhibits necroptosis
Anne von Maessenhausen et al.
CELL DEATH & DISEASE (2018)
The Effects of 2-O-Methoxyethyl Oligonucleotides on Renal Function in Humans
Stanley T. Crooke et al.
NUCLEIC ACID THERAPEUTICS (2018)
Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression
Esmeralda Castillo-Rodriguez et al.
TOXINS (2018)
Zebrafish as a Model for Drug Screening in Genetic Kidney Diseases
Jochen Gehrig et al.
FRONTIERS IN PEDIATRICS (2018)
Engineered Kidney Tubules for Modeling Patient-Specific Diseases and Drug Discovery
Valentina Benedetti et al.
EBIOMEDICINE (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
Howard Trachtman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories
Kyle J. Foreman et al.
LANCET (2018)
Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial
Dick de Zeeuw et al.
LANCET DIABETES & ENDOCRINOLOGY (2018)
The Avatar Acceptability Study: Survivor, Parent and Community Willingness to Use Patient-Derived Xenografts to Personalize Cancer Care
C. E. Wakefield et al.
EBIOMEDICINE (2018)
Polymer Therapeutics: Biomarkers and New Approaches for Personalized Cancer Treatment
Stuart P. Atkinson et al.
JOURNAL OF PERSONALIZED MEDICINE (2018)
Management of autosomal-dominant polycystic kidney disease-state-of-the-art
Roman-Ulrich Mueller et al.
CLINICAL KIDNEY JOURNAL (2018)
Emerging targeted strategies for the treatment of autosomal dominant polycystic kidney disease
Thomas Weimbs et al.
CLINICAL KIDNEY JOURNAL (2018)
Bortezomib for Reduction of Proteinuria in IgA Nephropathy
Choli Hartono et al.
KIDNEY INTERNATIONAL REPORTS (2018)
Ferroptosis, but Not Necroptosis, Is Important in Nephrotoxic Folic Acid-Induced AKI
Diego Martin-Sanchez et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Mitogen-Activated Protein Kinase 14 Promotes AKI
Alberto Ortiz et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Cellular senescence in renal ageing and disease
Ines Sturmlechner et al.
NATURE REVIEWS NEPHROLOGY (2017)
Renal targeting potential of a polymeric drug carrier, poly-L-glutamic acid, in normal and diabetic rats
Hann-Juang Chai et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Tubule-Derived Wnts Are Required for Fibroblast Activation and Kidney Fibrosis
Dong Zhou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Randomized Trial of C5a Receptor Inhibitor Avacopan in ANCA-Associated Vasculitis
David R. W. Jayne et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Treatment of membranous nephropathy: time for a paradigm shift
Piero Ruggenenti et al.
NATURE REVIEWS NEPHROLOGY (2017)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial
Theodoros Kassimatis et al.
TRIALS (2017)
Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial
David Z. I. Cherney et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Coordination-driven assembly of catechol-modified chitosan for the kidney-specific delivery of salvianolic acid B to treat renal fibrosis
Jing Li et al.
BIOMATERIALS SCIENCE (2017)
Enzyme replacement therapy for Anderson-Fabry disease: A complementary overview of a Cochrane publication through a linear regression and a pooled analysis of proportions from cohort studies
Regina El Dib et al.
PLOS ONE (2017)
MIF-2/D-DT enhances proximal tubular cell regeneration through SLPI- and ATF4-dependent mechanisms
Akinobu Ochi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2017)
Bcl3: a regulator of NF-κB inducible by TWEAK in acute kidney injury with anti-inflammatory and antiapoptotic properties in tubular cells
Jonay Poveda et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)
Radko Komers et al.
KIDNEY INTERNATIONAL REPORTS (2017)
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging
Marjolein P. Baar et al.
CELL (2017)
Complement Modulation of Anti-Aging Factor Klotho in Ischemia/Reperfusion Injury and Delayed Graft Function
G. Castellano et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2016)
A survey of current trends in computational drug repositioning
Jiao Li et al.
BRIEFINGS IN BIOINFORMATICS (2016)
NFκBiz protein downregulation in acute kidney injury: Modulation of inflammation and survival in tubular cells
Jonay Poveda et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)
Targeting inflammation in diabetic kidney disease: early clinical trials
Maria Vanessa Perez-Gomez et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
Elevated baseline glomerular filtration rate (GFR) is independently associated with a more rapid decline in renal function of patients with type 1 diabetes
Hilary J. Thomson et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry
Alberto Ortiz et al.
JOURNAL OF MEDICAL GENETICS (2016)
Increased urinary CD80 excretion and podocyturia in Fabry disease
H. Trimarchi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Darren J. Baker et al.
NATURE (2016)
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Incident chronic kidney disease: trends in management and outcomes
Robert M. Perkins et al.
CLINICAL KIDNEY JOURNAL (2016)
The Achilles' heel of senescent cells: from transcriptome to senolytic drugs
Yi Zhu et al.
AGING CELL (2015)
Precision-cut kidney slices (PCKS) to study development of renal fibrosis and efficacy of drug targeting ex vivo
Fariba Poosti et al.
DISEASE MODELS & MECHANISMS (2015)
Translational value of animal models of kidney failure
Alberto Ortiz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Lyso-Gb3 activates Notch1 in human podocytes
Maria D. Sanchez-Nino et al.
HUMAN MOLECULAR GENETICS (2015)
Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy A Randomized Clinical Trial
George L. Bakris et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Pharmacological GLI2 inhibition prevents myofibroblast cell-cycle progression and reduces kidney fibrosis
Rafael Kramann et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Well-Defined Star-Shaped Polyglutamates with Improved Pharmacokinetic Profiles As Excellent Candidates for Biomedical Applications
Aroa Duro-Castano et al.
MOLECULAR PHARMACEUTICS (2015)
Zebrafish as tools for drug discovery
Calum A. MacRae et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Diverse origins of the myofibroblast -implications for kidney fibrosis
Lucas L. Falke et al.
NATURE REVIEWS NEPHROLOGY (2015)
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome
Marc A. Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Albumin-induced apoptosis of tubular cells is modulated by BASP1
M. D. Sanchez-Nino et al.
CELL DEATH & DISEASE (2015)
Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function
Raquel Esteras et al.
THERAPEUTIC ADVANCES IN DRUG SAFETY (2015)
Tissue-engineered kidney disease models
Teresa M. DesRochers et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Kidney-specific drug delivery system for renal fibrosis based on coordination-driven assembly of catechol-derived chitosan
Hongzhi Qiao et al.
BIOMATERIALS (2014)
Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis
Ilse Daehn et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Bortezomib therapy for nephrotic syndrome due to idiopathic membranous nephropathy
Choli Hartono et al.
JOURNAL OF NEPHROLOGY (2014)
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival-an analysis of data from the ERA-EDTA Registry
Edwin M. Spithoven et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
CKD hotspots around the world: where, why and what the lessons are. A CKJ review series
Catalina Martin-Cleary et al.
CLINICAL KIDNEY JOURNAL (2014)
Tolvaptan Delays the Onset of End-Stage Renal Disease in a Polycystic Kidney Disease Model by Suppressing Increases in Kidney Volume and Renal Injury
Miki Aihara et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Polymer therapeutics-prospects for 21st century: The end of the beginning
Ruth Duncan et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Combined Angiotensin Inhibition for the Treatment of Diabetic Nephropathy
Linda F. Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
HCV Infection and Miravirsen
Maria D. Sanchez-Nino et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Fibrosis: a key feature of Fabry disease with potential therapeutic implications
Frank Weidemann et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
A Polymeric Nanomedicine Diminishes Inflammatory Events in Renal Tubular Cells
Alvaro C. Ucero et al.
PLOS ONE (2013)
Epithelial Cells as Active Player In Fibrosis: Findings from an In Vitro Model
Solange Moll et al.
PLOS ONE (2013)
Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials
Harikrishna Makani et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD
Nikolay O. Bukanov et al.
CELL CYCLE (2012)
Klotho, phosphate and inflammation/ageing in chronic kidney disease
Mara C. Izquierdo et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
Vicente E. Torres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Ginkgolide B inhibits renal cyst development in in vitro and in vivo cyst models
Hong Zhou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Antisense oligonucleotide suppression of serum amyloid A reduces amyloid deposition in mice with AA amyloidosis
Barbara Kluve-Beckerman et al.
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS (2011)
Single Application of Low-Dose Mycophenolate Mofetil-OX7-Immunoliposomes Ameliorates Experimental Mesangial Proliferative Glomerulonephritis
A. J. Suana et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
The Development of Atypical Hemolytic Uremic Syndrome Depends on Complement C5
Elena Goicoechea de Jorge et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
The Inflammatory Cytokines TWEAK and TNFα Reduce Renal Klotho Expression through NFκB
Juan A. Moreno et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Globotriaosylsphingosine actions on human glomerular podocytes: implications for Fabry nephropathy
Maria D. Sanchez-Nino et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis
Vinita Takiar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
p53 target Siva regulates apoptosis in ischemic kidneys
Kurinji Singaravelu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Tolvaptan inhibits ERK-dependent cell proliferation, Cl- secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin
Gail A. Reif et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
The Senescence-Associated Secretory Phenotype: The Dark Side of Tumor Suppression
Jean -Philippe Coppe et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2010)
BASP1 Promotes Apoptosis in Diabetic Nephropathy
Maria Dolores Sanchez-Nino et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models
Thomas A. Natoli et al.
NATURE MEDICINE (2010)
Sorafenib inhibits cAMP-dependent ERK activation, cell proliferation, and in vitro cyst growth of human ADPKD cyst epithelial cells
Tamio Yamaguchi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2010)
Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury
Felix Heymann et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
The MIF Receptor CD74 in Diabetic Podocyte Injury
Maria Dolores Sanchez-Nino et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Anti-α8 Integrin Immunoliposomes in Glomeruli of Lupus-Susceptible Mice A Novel System for Delivery of Therapeutic Agents to the Renal Glomerulus in Systemic Lupus Erythematosus
Yogesh Scindia et al.
ARTHRITIS AND RHEUMATISM (2008)
Podocyte-Selective Deletion of Dicer Induces Proteinuria and Glomerulosclerosis
Shaolin Shi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study):: a multicentre, randomised, double-blind, controlled trial
Johannes F. E. Mann et al.
LANCET (2008)
An efficient and versatile system for acute and chronic modulation of renal tubular function in transgenic mice
Milena Traykova-Brauch et al.
NATURE MEDICINE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded Ab(Esel) liposomes
Sigridur A. Asgeirdottir et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Autosomal dominant polycystic kidney disease
Vicente E. Torres et al.
LANCET (2007)
Randomly 50% N-acetylated low molecular weight chitosan as a novel renal targeting carrier
Zhi-Xiang Yuan et al.
JOURNAL OF DRUG TARGETING (2007)
Synthesis of a poly(vinylpyrrolidone-co-dimethyl maleic anhydride) co-polymer and its application for renal drug targeting
H Kamada et al.
NATURE BIOTECHNOLOGY (2003)
Centenarians as a model for healthy aging
C Franceschi et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2003)
Effect of endothelin-A receptor blockade with atrasentan on tumor progression in men with hormone-refractory prostate cancer: A randomized, phase II, placebo-controlled trial
MA Carducci et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
BM Brenner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
EJ Lewis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Angiotensin II and renal fibrosis
SA Mezzano et al.
HYPERTENSION (2001)
Share Paper
